Zelcer N - Search Results

1

Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins.

Cummings J, Zelcer N, Allen JD, Yao D, Boyd G, Maliepaard M, Friedberg TH, Smyth JF, Jodrell DI. Cummings J, et al. Among authors: zelcer n. Biochem Pharmacol. 2004 Jan 1;67(1):31-9. doi: 10.1016/j.bcp.2003.07.019. Biochem Pharmacol. 2004. PMID: 14667926

2

Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5.

Reid G, Wielinga P, Zelcer N, De Haas M, Van Deemter L, Wijnholds J, Balzarini J, Borst P. Reid G, et al. Among authors: zelcer n. Mol Pharmacol. 2003 May;63(5):1094-103. doi: 10.1124/mol.63.5.1094. Mol Pharmacol. 2003. PMID: 12695538

3

Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.

Zelcer N, Saeki T, Bot I, Kuil A, Borst P. Zelcer N, et al. Biochem J. 2003 Jan 1;369(Pt 1):23-30. doi: 10.1042/BJ20021081. Biochem J. 2003. PMID: 12220224 Free PMC article.

4

Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).

Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, Borst P. Zelcer N, et al. Biochem J. 2003 Apr 15;371(Pt 2):361-7. doi: 10.1042/BJ20021886. Biochem J. 2003. PMID: 12523936 Free PMC article.

5

Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.

Breedveld P, Zelcer N, Pluim D, Sönmezer O, Tibben MM, Beijnen JH, Schinkel AH, van Tellingen O, Borst P, Schellens JH. Breedveld P, et al. Among authors: zelcer n. Cancer Res. 2004 Aug 15;64(16):5804-11. doi: 10.1158/0008-5472.CAN-03-4062. Cancer Res. 2004. PMID: 15313923

6

Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides.

van de Wetering K, Zelcer N, Kuil A, Feddema W, Hillebrand M, Vlaming ML, Schinkel AH, Beijnen JH, Borst P. van de Wetering K, et al. Among authors: zelcer n. Mol Pharmacol. 2007 Aug;72(2):387-94. doi: 10.1124/mol.107.035592. Epub 2007 May 7. Mol Pharmacol. 2007. PMID: 17485564

7

On the putative co-transport of drugs by multidrug resistance proteins.

Borst P, Zelcer N, van de Wetering K, Poolman B. Borst P, et al. Among authors: zelcer n. FEBS Lett. 2006 Feb 13;580(4):1085-93. doi: 10.1016/j.febslet.2005.12.039. Epub 2005 Dec 20. FEBS Lett. 2006. PMID: 16386247 Free article. Review.

8

Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3).

Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P. Zelcer N, et al. J Biol Chem. 2001 Dec 7;276(49):46400-7. doi: 10.1074/jbc.M107041200. J Biol Chem. 2001. PMID: 11581266 Free article.

9

Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.

Huisman MT, Smit JW, Crommentuyn KM, Zelcer N, Wiltshire HR, Beijnen JH, Schinkel AH. Huisman MT, et al. Among authors: zelcer n. AIDS. 2002 Nov 22;16(17):2295-301. doi: 10.1097/00002030-200211220-00009. AIDS. 2002. PMID: 12441801

10

The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.

Wielinga P, Hooijberg JH, Gunnarsdottir S, Kathmann I, Reid G, Zelcer N, van der Born K, de Haas M, van der Heijden I, Kaspers G, Wijnholds J, Jansen G, Peters G, Borst P. Wielinga P, et al. Among authors: zelcer n. Cancer Res. 2005 May 15;65(10):4425-30. doi: 10.1158/0008-5472.CAN-04-2810. Cancer Res. 2005. PMID: 15899835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters